StockWatch: Patient Death, Rival’s Patent Challenge Sink Erasca Shares
negativeERAS-0015Negative
AI Analysis
Summary
A 66-year-old patient with heavily pretreated metastatic pancreatic cancer died from grade 5 pneumonitis after receiving ERAS-0015 (24 mg), a treatment-related adverse event that progressed after supportive care was withdrawn at the patient's direction.
Outcome Details
Patient death from grade 5 pneumonitis (treatment-related adverse event) after supportive care withdrawal
Importance:8/10
Sentiment:
-0.90
adverse_eventpatient_deathsafetypneumonitispancreatic_cancerclinical_trialstock_decline
Related Companies
Read the original article
Published by GEN - Genetic Engineering & Biotech News on May 3, 2026 6:40 PM